J. M. Miró

419 total citations
9 papers, 188 citations indexed

About

J. M. Miró is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, J. M. Miró has authored 9 papers receiving a total of 188 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 6 papers in Epidemiology and 2 papers in Pharmacology. Recurrent topics in J. M. Miró's work include Infective Endocarditis Diagnosis and Management (4 papers), Antimicrobial Resistance in Staphylococcus (4 papers) and Toxoplasma gondii Research Studies (2 papers). J. M. Miró is often cited by papers focused on Infective Endocarditis Diagnosis and Management (4 papers), Antimicrobial Resistance in Staphylococcus (4 papers) and Toxoplasma gondii Research Studies (2 papers). J. M. Miró collaborates with scholars based in Spain, France and Switzerland. J. M. Miró's co-authors include Asunción Moreno, José M. Gatell, Francesc Marco, Dolors Soy, Carlos A. Mestres, Yolanda Armero, Manel Almela, Ana del Rı́o, Cristina García de la Mària and Fernando Agüero and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy and Clinical Microbiology and Infection.

In The Last Decade

J. M. Miró

9 papers receiving 183 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. M. Miró Spain	6	145	125	47	43	28	9	188
William Vindrios France	7	115 0.8×	100 0.8×	30 0.6×	24 0.6×	26 0.9×	15	174
Márcia Halpern Brazil	11	113 0.8×	154 1.2×	20 0.4×	16 0.4×	39 1.4×	18	246
Samia Arshad United States	9	134 0.9×	118 0.9×	21 0.4×	46 1.1×	24 0.9×	16	219
Natalia Montiel Spain	8	80 0.6×	158 1.3×	44 0.9×	48 1.1×	7 0.3×	24	255
Sara Mazzanti Italy	9	164 1.1×	127 1.0×	9 0.2×	17 0.4×	19 0.7×	12	264
Cristina Mogdasy Uruguay	9	96 0.7×	153 1.2×	38 0.8×	31 0.7×	10 0.4×	18	249
Lawrence Eisenstein United States	8	79 0.5×	90 0.7×	29 0.6×	47 1.1×	38 1.4×	12	191
Justin Albertson United States	4	116 0.8×	114 0.9×	32 0.7×	57 1.3×	42 1.5×	6	184
Martina Spaziante Italy	9	76 0.5×	76 0.6×	29 0.6×	22 0.5×	17 0.6×	24	198
Laura Campogiani Italy	9	95 0.7×	69 0.6×	25 0.5×	16 0.4×	28 1.0×	32	222

Countries citing papers authored by J. M. Miró

Since Specialization

Citations

This map shows the geographic impact of J. M. Miró's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. M. Miró with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. M. Miró more than expected).

Fields of papers citing papers by J. M. Miró

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. M. Miró. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. M. Miró. The network helps show where J. M. Miró may publish in the future.

Co-authorship network of co-authors of J. M. Miró

This figure shows the co-authorship network connecting the top 25 collaborators of J. M. Miró. A scholar is included among the top collaborators of J. M. Miró based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. M. Miró. J. M. Miró is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Londoño, María‐Carlota, Christian Manzardo, Antoni Rimola, et al.. (2016). IFN-free therapy for HIV/HCV-coinfected patients within the liver transplant setting. Journal of Antimicrobial Chemotherapy. 71(11). 3195–3201. 6 indexed citations

Pericàs, Juan M., Carlos Cervera, Ana del Rı́o, et al.. (2014). Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone. Clinical Microbiology and Infection. 20(12). O1075–O1083. 66 indexed citations

Miró, J. M., et al.. (2014). Infections in solid organ transplant HIV-infected patients. Clinical Microbiology and Infection. 20. 119–130. 24 indexed citations

Tattevin, Pierre, Azzam Saleh‐Mghir, Benjamin Davido, et al.. (2012). Comparison of Six Generic Vancomycin Products for Treatment of Methicillin-Resistant Staphylococcus aureus Experimental Endocarditis in Rabbits. Antimicrobial Agents and Chemotherapy. 57(3). 1157–1162. 23 indexed citations

Olaechea, Pedro, et al.. (2009). Evaluation of the status of patients with severe infection, criteria for intensive care unit admittance.. Enfermedades Infecciosas y Microbiología Clínica. 27(6). 342–352. 1 indexed citations

Gudiol, Francesc, José María Aguado, Álvaro Pascual, et al.. (2009). Consensus document for the treatment of bacteremia and endicarditis caused by methicillin-resistent Staphylococcus aureus.. Enfermedades Infecciosas y Microbiología Clínica. 27(2). 105–115. 17 indexed citations

Miró, J. M., C. García-de-la-Mària, Yolanda Armero, et al.. (2009). Addition of Gentamicin or Rifampin Does Not Enhance the Effectiveness of Daptomycin in Treatment of Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 53(10). 4172–4177. 47 indexed citations

Guelar, Ana, et al.. (1994). [Therapeutic alternatives for cases of cerebral toxoplasmosis in patients with AIDS: clarithromycin and atovaquone].. PubMed. 12(3). 137–40. 1 indexed citations

González-Clemente, José-Miguel, J. M. Miró, Enric Pedrol, et al.. (1990). [Encephalic toxoplasmosis in patients with the acquired immunodeficiency syndrome. A clinico-radiological study and the therapeutic results in 78 cases].. PubMed. 95(12). 441–6. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact